BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/21/2018 1:32:15 AM | Browse: 846 | Download: 923
Publication Name World Journal of Clinical Oncology
Manuscript ID 41182
Country United States
Received
2018-08-03 00:49
Peer-Review Started
2018-08-04 07:15
To Make the First Decision
2018-09-03 01:47
Return for Revision
2018-09-10 09:12
Revised
2018-09-20 20:34
Second Decision
2018-11-23 10:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-11-27 04:43
Articles in Press
2018-11-27 04:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-12-17 03:14
Publish the Manuscript Online
2018-12-21 01:32
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Role of senescence induction in cancer treatment
Manuscript Source Invited Manuscript
All Author List Shenghui Qin, Bradley A Schulte and Gavin Yong Wang
ORCID
Author(s) ORCID Number
Shenghui Qin http://orcid.org/0000-0002-0275-133X
Bradley A Schulte http://orcid.org/0000-0001-8044-8240
Gavin Yong Wang http://orcid.org/0000-0002-0186-6098
Funding Agency and Grant Number
Corresponding Author Gavin Yong Wang, MD, PhD, Assistant Professor, Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 171 Ashley Avenue, MSC908, Charleston, SC 29425, United States. wangy@musc.edu
Key Words Cellular senescence; Cancer treatment; Chemotherapy; Ionizing radiation; Cyclin-dependent kinases 4/6 inhibitor; Aurora kinase inhibitor; Immunotherapy; T helper-1 cells; Th1 cytokines
Core Tip Both in vitro and in vivo studies have revealed that senescence induction in human cancer cells is a prominent response to chemotherapy and irradiation. A senescent phenotype has been detected in clinical tumor samples of breast cancer patients following preoperative neoadjuvant chemotherapy. Immunotherapy-induced senescence of cancer cells contributes to tumor regression in vivo. The induction of cancer cell senescence appears to be a major mechanism of action of cyclin-dependent kinases 4/6 small molecule inhibitor-based targeted therapy. Collectively, these preclinical and clinical observations have demonstrated an important role for senescence induction in cancer treatment.
Publish Date 2018-12-21 01:32
Citation Qin S, Schulte BA, Wang GY. Role of senescence induction in cancer treatment. World J Clin Oncol 2018; 9(8): 180-187
URL https://www.wjgnet.com/2218-4333/full/v9/i8/180.htm
DOI https://dx.doi.org/10.5306/wjco.v9.i8.180
Full Article (PDF) WJCO-9-180.pdf
Full Article (Word) WJCO-9-180.doc
Manuscript File 41182-Review.docx
Answering Reviewers 41182-Answering reviewers.pdf
Audio Core Tip 41182-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 41182-Conflict-of-interest statement.pdf
Copyright License Agreement 41182-Copyright assignmentn.pdf
Peer-review Report 41182-Peer-review(s).pdf
Scientific Misconduct Check 41182-Scientific misconduct check.pdf
Scientific Editor Work List 41182-Scientific editor work list.pdf